Group III (<1% whole population) represents the ATM-mutated patients with no functional ATM kinase or those who show strong DSB repair defects (like the LIG4-mutated patient described above), hyper-radiosensitivity, and either high cancer proneness or severe accelerated aging [12,73]. This evidence concerns the gene ATM and cancer.